Clinical Trial: RCI001 Eye Drops 0.25% in Healthy Adult Male Participants

U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07640867) titled 'RCI001 Eye Drops 0.25% in Healthy Adult Male Participants' on May 12.

Brief Summary: This study is being conducted to evaluate the safety, tolerability, and pharmacokinetics of RCI001 eye drops 0.25% in healthy adult male participants. Pharmacokinetics means how the study drug is absorbed, distributed, and eliminated from the body over time.

Participants who meet the study requirements will be randomly assigned to receive either RCI001 eye drops 0.25% or placebo eye drops. The study treatment will be administered to the left eye according to the assigned dosing schedule. The study includes single-dose administration schedules and m...